American Society of Hirudotherapy

Mental health is strongly associated with capability after lower extremity injury treated with free flap limb salvage or amputation.

Review published in European journal of trauma and emergency surgery : official publication of the European Trauma Society (2024)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewClinical TrialsKrijgh et al. · European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2024

Abstract

BACKGROUND: Knowledge about factors associated with long-term outcomes, after severe traumatic injury to the lower extremity, can aid with the difficult decision whether to salvage or amputate the leg and improve outcome. We therefore studied factors independently associated with capability at a minimum of 1 year after amputation or free flap limb salvage. METHODS: We included 135 subjects with a free flap lower extremity reconstruction and 41 subjects with amputation, between 1991 and 2021 at two urban-level 1 trauma centers with a mean follow-up of 11 ± 7 years. Long-term physical functioning was assessed using the Physical Component Score (PCS) of the Short-Form 36 (SF36) and the Lower Extremity Functional Scale (LEFS) questionnaires. Independent variables included demographics, injury characteristics, and the Mental Component Score (MCS) of the SF36. RESULTS: Greater mental health was independently and strongly associated with greater capability, independent of amputation or limb reconstruction. Mental health explained 33% of the variation in PCS and 57% of the variation in LEFS. Injury location at the knee or leg was associated with greater capability, compared to the foot or ankle. Amputation or limb reconstruction was not associated with capability. DISCUSSION: This study adds to the growing body of knowledge that physical health is best regarded through the lens of the bio-psycho-social model in which mental health is a strong determinant. This study supports making mental health an important aspect of rehabilitation after major lower extremity injury, regardless of amputation or limb salvage.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsHumansMaleFemaleLimb SalvageAmputation, SurgicalLeg InjuriesFree Tissue FlapsAdultMental HealthMiddle AgedRetrospective StudiesPlastic Surgery Procedures

Summary

Knowledge about factors associated with long-term outcomes, after severe traumatic injury to the lower extremity, can aid with the difficult decision whether to salvage or amputate the leg and improve outcome. We therefore studied factors independently associated with capability at a minimum of 1...

Why This Matters for Hirudotherapy

This study examined factors associated with long-term physical capability in 176 subjects (135 free flap reconstructions, 41 amputations) following severe lower extremity trauma, with a mean follow-up of 11±7 years. Greater mental health was independently and strongly associated with greater capability regardless of whether patients underwent amputation or limb reconstruction. The abstract contains no mention of leeches, hirudotherapy, venous congestion, or leech-derived interventions. There is no defensible connection to ASH's domain, as the study focuses on mental health and psychosocial determinants of rehabilitation outcomes.

Citation

Mental health is strongly associated with capability after lower extremity injury treated with free flap limb salvage or amputation.

Krijgh et al. · European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2024

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.